The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

Oscar Health's targets of a 20% revenue CAGR through 2027 and 5% operating margin imply operating income around $700m in 3 ...

We recently compiled a list of the Billionaire Lee Cooperman’s Top 15 Long-Term Stock Picks. In this article, we are going to ...